MGAWN1

BIOLOGICAL3 trials

Sponsors

MacroGenics

Conditions

Acute Flaccid ParalysisEncephalitisMeningitisWest Nile FeverWest Nile Neuroinvasive DiseaseWest Nile VirusWest Nile Virus Infection

Phase 1

A Trial to Evaluate the Safety of a Single Intravenous Infusion of MGAWN1 in Healthy Adults

CompletedNCT00515385

MacroGenicsWest Nile Virus

Start: 2007-08-31End: 2009-01-31Updated: 2022-02-22

Phase 2

Treatment of West Nile Virus With MGAWN1

TerminatedNCT00927953

MacroGenicsAcute Flaccid Paralysis, Encephalitis, Meningitis +3

Start: 2009-05-31End: 2011-05-31Updated: 2022-02-10

Unknown Phase

Expanded Access to MGAWN1 in Subjects With Suspected West Nile Neuroinvasive Disease; Suspected West Nile Virus Infection; or Substantial Accidental Exposure

MacroGenicsWest Nile Virus Infection

Updated: 2022-02-22